HomeNDC LookupRxCUI directory › RxCUI 866514

Metoprolol tartrate 50 MG Oral Tablet — RxCUI 866514

RxNorm drug concept · Semantic clinical drug
RxCUI 866514 Semantic clinical drug · SCD ● Current RxNorm concept 127 FDA products 349 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI866514
Official nameMetoprolol tartrate 50 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped127
Package NDCs mapped349
Reported Medicaid activity (SDUD)1,908,474 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Metoprolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That depends on why you were prescribed it. Metoprolol is a beta-blocker, which means it slows your heart rate and reduces the workload on your heart. Depending on your formulation...
  • What exactly is metoprolol supposed to do for me?
  • Please don't stop suddenly — this is one of the most important things to know about this drug. Stopping metoprolol abruptly, especially if you have any heart disease, can cause you...
  • Can I stop taking metoprolol if I feel fine or if it makes me tired?
📖 Read our full Metoprolol guide →

🕸️ Concept Web — How Metoprolol tartrate 50 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Metoprolol tartrate 50 MG Oral Tablet RxCUI 866514

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Metoprolol 6918
    • Metoprolol tartrate 203191
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lopressor 203344
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Metoprolol Oral Tablet 372891
    • Metoprolol tartrate Oral Tablet 2646152
    • Metoprolol Oral Product 1163523
    • Metoprolol Pill 1163524
    • Metoprolol tartrate Oral Product 2661227
    • Metoprolol tartrate Pill 2662374
    • Metoprolol Oral Tablet [Lopressor] 368757
    • Metoprolol tartrate Oral Tablet [Lopressor] 2657102
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Metoprolol tartrate 50 MG SCDC · 866435
  • Metoprolol Oral Tablet SCDF · 372891
  • Metoprolol tartrate Oral Tablet SCDFP · 2646152
  • Metoprolol Oral Product SCDG · 1163523
  • Metoprolol Pill SCDG · 1163524
  • Metoprolol tartrate Oral Product SCDGP · 2661227
  • Metoprolol tartrate Pill SCDGP · 2662374

Brand-Name Concepts

  • Metoprolol tartrate 50 MG Oral Tablet [Lopressor] SBD · 866516
  • Metoprolol tartrate 50 MG [Lopressor] SBDC · 866515
  • Metoprolol Oral Tablet [Lopressor] SBDF · 368757
  • Metoprolol tartrate Oral Tablet [Lopressor] SBDFP · 2657102
  • Lopressor Oral Product SBDG · 1180279
  • Lopressor Pill SBDG · 1180280
  • Lopressor BN · 203344

📦 FDA Products & Package NDCs

127 products · 349 package NDCs
349 package NDCs map to RxCUI 866514 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
76420-0953-00 1000 TABLET, FILM COATED in 1 BOTTLE (76420-953-00) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0953-01 100 TABLET, FILM COATED in 1 BOTTLE (76420-953-01) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0953-20 20 TABLET, FILM COATED in 1 BOTTLE (76420-953-20) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0953-30 30 TABLET, FILM COATED in 1 BOTTLE (76420-953-30) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0953-60 60 TABLET, FILM COATED in 1 BOTTLE (76420-953-60) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0953-90 90 TABLET, FILM COATED in 1 BOTTLE (76420-953-90) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0954-00 1000 TABLET, FILM COATED in 1 BOTTLE (76420-954-00) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0954-01 100 TABLET, FILM COATED in 1 BOTTLE (76420-954-01) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0954-20 20 TABLET, FILM COATED in 1 BOTTLE (76420-954-20) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0954-30 30 TABLET, FILM COATED in 1 BOTTLE (76420-954-30) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0954-60 60 TABLET, FILM COATED in 1 BOTTLE (76420-954-60) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
76420-0954-90 90 TABLET, FILM COATED in 1 BOTTLE (76420-954-90) Metoprolol Tartrate Asclemed USA, Inc. 2025-03-18
82804-0165-90 90 TABLET, FILM COATED in 1 BOTTLE (82804-165-90) Metoprolol Tartrate Proficient Rx LP 2024-12-16
82804-0253-30 30 TABLET in 1 BOTTLE (82804-253-30) METOPROLOL TARTRATE Proficient Rx LP 2026-01-09
82804-0253-90 90 TABLET in 1 BOTTLE (82804-253-90) METOPROLOL TARTRATE Proficient Rx LP 2025-11-04
82804-0978-00 100 TABLET in 1 BOTTLE (82804-978-00) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0978-11 1000 TABLET in 1 BOTTLE (82804-978-11) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0978-30 30 TABLET in 1 BOTTLE (82804-978-30) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0978-55 500 TABLET in 1 BOTTLE (82804-978-55) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0978-60 60 TABLET in 1 BOTTLE (82804-978-60) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0978-90 90 TABLET in 1 BOTTLE (82804-978-90) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0979-00 100 TABLET in 1 BOTTLE (82804-979-00) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0979-11 1000 TABLET in 1 BOTTLE (82804-979-11) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0979-30 30 TABLET in 1 BOTTLE (82804-979-30) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0979-55 500 TABLET in 1 BOTTLE (82804-979-55) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0979-60 60 TABLET in 1 BOTTLE (82804-979-60) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82804-0979-90 90 TABLET in 1 BOTTLE (82804-979-90) Metoprolol Tartrate Proficient Rx LP 2025-03-11
82868-0090-30 30 TABLET in 1 BOTTLE, PLASTIC (82868-090-30) METOPROLOL TARTRATE Northwind Health Company, LLC 2025-10-07
82868-0090-90 90 TABLET in 1 BOTTLE, PLASTIC (82868-090-90) METOPROLOL TARTRATE Northwind Health Company, LLC 2026-02-19
87063-0184-01 100 TABLET in 1 BOTTLE (87063-184-01) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0184-30 30 TABLET in 1 BOTTLE (87063-184-30) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0184-60 60 TABLET in 1 BOTTLE (87063-184-60) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0184-90 90 TABLET in 1 BOTTLE (87063-184-90) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0185-01 100 TABLET in 1 BOTTLE (87063-185-01) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0185-30 30 TABLET in 1 BOTTLE (87063-185-30) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0185-60 60 TABLET in 1 BOTTLE (87063-185-60) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0185-90 90 TABLET in 1 BOTTLE (87063-185-90) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0186-01 100 TABLET in 1 BOTTLE (87063-186-01) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0186-30 30 TABLET in 1 BOTTLE (87063-186-30) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0186-60 60 TABLET in 1 BOTTLE (87063-186-60) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0186-90 90 TABLET in 1 BOTTLE (87063-186-90) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0187-01 100 TABLET in 1 BOTTLE (87063-187-01) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0187-30 30 TABLET in 1 BOTTLE (87063-187-30) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0187-60 60 TABLET in 1 BOTTLE (87063-187-60) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0187-90 90 TABLET in 1 BOTTLE (87063-187-90) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0188-01 100 TABLET in 1 BOTTLE (87063-188-01) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0188-30 30 TABLET in 1 BOTTLE (87063-188-30) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0188-60 60 TABLET in 1 BOTTLE (87063-188-60) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
87063-0188-90 90 TABLET in 1 BOTTLE (87063-188-90) METOPROLOL TARTRATE ASCLEMED USA INC. 2026-05-18
Observed labelers: A-S Medication Solutions (37) · Aphena Pharma Solutions - Tennessee, LLC (35) · Bryant Ranch Prepack (32) · Proficient Rx LP (24) · ASCLEMED USA INC. (20) · Asclemed USA, Inc. (18) · +30 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.